Insurance

MetLife’s 3.1 million‑share Rule 144 sale sparks questions about timing, institutional motives, and impact on employee 401(k) plans.

Everest Group Ltd. boosts production, secures OEM deals, and rebalances capital amid modest revenue dip—investors eye operational gains and new financing moves.

Allianz’s share price dipped amid German blue‑chip pullback and tighter regulation, yet its scale, ESG focus and digital push keep it a solid long‑term play for savvy investors.

Explore how Aflac’s officer purchases and Japan Post’s trust‑based stake reveal confidence in U.S. insurance growth, governance trends, and regulatory relief—key insights for institutional investors.

Zurich Insurance’s recent trading of Beazley shares shows disciplined, narrow‑price market‑making—no hidden strategy to sway Beazley’s governance.

Discover how Aon plc’s 2026 debt issuance powers its acquisition of USI Advantage, boosting data‑driven underwriting and setting a new benchmark for tech‑enabled risk solutions.

Marsh & McLennan Q3 2026 earnings unveil: analyze revenue, capital, risk, and conflict‑of‑interest issues shaping the firm’s future and client trust.

Sun Life’s repeat “Top Workplace” awards spark debate: Are employee perks genuine or PR tactics tied to exec bonuses and limited ROI?

Munich Re’s 2.5 M‑share buyback continues at €507‑per‑share, boosting EPS and shareholder value while staying compliant with Solvency IV and market stability.

Discover how Allianz SE’s solid dividend yield, strong core profits, and bold moves into autonomous mobility and tech investing can benefit long‑term investors.